Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387080306> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4387080306 abstract "Abstract Background Detection of anti-double stranded DNA antibodies (anti-dsDNA) by the indirect fluorescent antibody (IFA) assay is a well-established tool for aiding in the diagnosis of systemic lupus erythematosus (SLE). ZEUS Scientific has manufactured an FDA-cleared anti-dsDNA IFA test system for decades, which relies upon manual interpretation of qualitative results using a standard fluorescent microscope. This same anti-dsDNA IFA test system was recently utilized to train software, in conjunction with a specialized fluorescent microscope (collectively termed dIFine), towards automating qualitative result interpretation. The objective of this study was to validate the reproducibility, sensitivity, and specificity of the ZEUS anti-dsDNA IFA test system, in conjunction with the dIFine automated microscope. Methods Multi-site reproducibility study–2 low-positive, 2 mid-positive, 2 high-positive, and 2 negative serum samples were assembled to create a reproducibility panel. The sample identities of the panel members were scrambled prior to testing. The panel was assayed via the ZEUS anti-dsDNA-IFA test system at a 1:10 screening dilution, in triplicate, twice per day, on five days, at three different laboratories (including ZEUS Scientific). At each laboratory, the processed slides were interpreted manually by two operators, then scanned by dIFine to generate digital images of the wells, as well as an automated qualitative result interpretation. The digital images of each slide well were also interpreted by two operators, resulting in 3 independent interpretations per sample, for each operator and instrument (Manual, Digital, Automated). The number of slide wells processed for interpretation at each laboratory was: 8 samples × 30 replicates each = 240 total. Clinical study–300 serum samples derived from donors previously diagnosed with SLE were assembled. A control cohort consisting of 360 samples from donors previously diagnosed with other rheumatic and non-rheumatic diseases was also assembled. The sample identities were scrambled for both cohorts prior to testing. The 660 samples were assayed at a 1:10 screening dilution using the ZEUS anti-dsDNA IFA test system at ZEUS Scientific. Manual, digital, and automated interpretations were carried out at ZEUS Scientific as described above. Results Reproducibility (Actual/Expected): [Site 1 - Operator A - Manual (240/240), Digital (240/240); Site 1 - Operator B - Manual (240/240), Digital (240/240); Site 1 - Automated - (231/240)]. [Site 2 - Operator A - Manual (240/240), Digital (240/240); [Site 2 - Operator B - Manual (240/240), Digital (240/240); Site 2 - Automated - (236/240)]. [Site 3 - Operator A - Manual (240/240), Digital (238/240); Site 3 - Operator B - Manual (240/240), Digital (238/240); Site 3 - Automated - (231/240)]. Sensitivity for SLE cohort (Positive/Total, %): [Operator A - Manual, (79/300, 26.3%), Digital (79/300, 26.3%)]; [Operator B - Manual, (79/300, 26.3%), Digital (79/300, 26.3%), Automated (81/300, 27.0%)]. Specificity for control cohort (Negative/Total): [Operator A - Manual, (358/360, 99.4%), Digital (358/360, 99.4%)]; [Operator B - Manual, (358/360, 99.4%), Digital (358/360, 99.4%), Automated (358/360, 99.4%)]. Conclusions These validation studies demonstrate that the ZEUS anti-dsDNA-IFA test system, in conjunction with the automated dIFine microscope, yields highly reproducible and accurate results derived from digital and automated interpretations." @default.
- W4387080306 created "2023-09-28" @default.
- W4387080306 creator A5007278859 @default.
- W4387080306 creator A5015598520 @default.
- W4387080306 creator A5018888871 @default.
- W4387080306 creator A5030061240 @default.
- W4387080306 creator A5048947122 @default.
- W4387080306 creator A5092951045 @default.
- W4387080306 creator A5092951046 @default.
- W4387080306 creator A5092951047 @default.
- W4387080306 date "2023-09-27" @default.
- W4387080306 modified "2023-09-28" @default.
- W4387080306 title "B-110 Validation of Digital and Automated anti-dsDNA IFA Interpretations Using the dIFine Automated Fluorescent Microscope System" @default.
- W4387080306 doi "https://doi.org/10.1093/clinchem/hvad097.449" @default.
- W4387080306 hasPublicationYear "2023" @default.
- W4387080306 type Work @default.
- W4387080306 citedByCount "0" @default.
- W4387080306 crossrefType "journal-article" @default.
- W4387080306 hasAuthorship W4387080306A5007278859 @default.
- W4387080306 hasAuthorship W4387080306A5015598520 @default.
- W4387080306 hasAuthorship W4387080306A5018888871 @default.
- W4387080306 hasAuthorship W4387080306A5030061240 @default.
- W4387080306 hasAuthorship W4387080306A5048947122 @default.
- W4387080306 hasAuthorship W4387080306A5092951045 @default.
- W4387080306 hasAuthorship W4387080306A5092951046 @default.
- W4387080306 hasAuthorship W4387080306A5092951047 @default.
- W4387080306 hasBestOaLocation W43870803061 @default.
- W4387080306 hasConcept C120665830 @default.
- W4387080306 hasConcept C121332964 @default.
- W4387080306 hasConcept C126894567 @default.
- W4387080306 hasConcept C136229726 @default.
- W4387080306 hasConcept C138944611 @default.
- W4387080306 hasConcept C142199849 @default.
- W4387080306 hasConcept C142724271 @default.
- W4387080306 hasConcept C169274487 @default.
- W4387080306 hasConcept C185592680 @default.
- W4387080306 hasConcept C191486275 @default.
- W4387080306 hasConcept C198531522 @default.
- W4387080306 hasConcept C2776444479 @default.
- W4387080306 hasConcept C34862184 @default.
- W4387080306 hasConcept C41008148 @default.
- W4387080306 hasConcept C43617362 @default.
- W4387080306 hasConcept C67649825 @default.
- W4387080306 hasConcept C71924100 @default.
- W4387080306 hasConcept C89473665 @default.
- W4387080306 hasConcept C91881484 @default.
- W4387080306 hasConcept C9893847 @default.
- W4387080306 hasConceptScore W4387080306C120665830 @default.
- W4387080306 hasConceptScore W4387080306C121332964 @default.
- W4387080306 hasConceptScore W4387080306C126894567 @default.
- W4387080306 hasConceptScore W4387080306C136229726 @default.
- W4387080306 hasConceptScore W4387080306C138944611 @default.
- W4387080306 hasConceptScore W4387080306C142199849 @default.
- W4387080306 hasConceptScore W4387080306C142724271 @default.
- W4387080306 hasConceptScore W4387080306C169274487 @default.
- W4387080306 hasConceptScore W4387080306C185592680 @default.
- W4387080306 hasConceptScore W4387080306C191486275 @default.
- W4387080306 hasConceptScore W4387080306C198531522 @default.
- W4387080306 hasConceptScore W4387080306C2776444479 @default.
- W4387080306 hasConceptScore W4387080306C34862184 @default.
- W4387080306 hasConceptScore W4387080306C41008148 @default.
- W4387080306 hasConceptScore W4387080306C43617362 @default.
- W4387080306 hasConceptScore W4387080306C67649825 @default.
- W4387080306 hasConceptScore W4387080306C71924100 @default.
- W4387080306 hasConceptScore W4387080306C89473665 @default.
- W4387080306 hasConceptScore W4387080306C91881484 @default.
- W4387080306 hasConceptScore W4387080306C9893847 @default.
- W4387080306 hasIssue "Supplement_1" @default.
- W4387080306 hasLocation W43870803061 @default.
- W4387080306 hasOpenAccess W4387080306 @default.
- W4387080306 hasPrimaryLocation W43870803061 @default.
- W4387080306 hasRelatedWork W1598789855 @default.
- W4387080306 hasRelatedWork W2023374948 @default.
- W4387080306 hasRelatedWork W2083666934 @default.
- W4387080306 hasRelatedWork W2348803856 @default.
- W4387080306 hasRelatedWork W2913163527 @default.
- W4387080306 hasRelatedWork W2914892364 @default.
- W4387080306 hasRelatedWork W2922137816 @default.
- W4387080306 hasRelatedWork W3014119846 @default.
- W4387080306 hasRelatedWork W4312123619 @default.
- W4387080306 hasRelatedWork W3151459851 @default.
- W4387080306 hasVolume "69" @default.
- W4387080306 isParatext "false" @default.
- W4387080306 isRetracted "false" @default.
- W4387080306 workType "article" @default.